149 related articles for article (PubMed ID: 570069)
1. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R
Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
[TBL] [Abstract][Full Text] [Related]
3. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
[TBL] [Abstract][Full Text] [Related]
4. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
Chen SH
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
[TBL] [Abstract][Full Text] [Related]
5. Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura.
Lian EC; Savaraj N
Blood; 1981 Aug; 58(2):354-9. PubMed ID: 6264998
[TBL] [Abstract][Full Text] [Related]
6. A platelet aggregating factor in thrombotic thrombocytopenic purpura: initial activity, fluctuations, and removal by plasma exchange.
Hussey CV; Hause LL; Gottschall JL; Anderson T
Thromb Res; 1986 Nov; 44(3):355-64. PubMed ID: 3798403
[TBL] [Abstract][Full Text] [Related]
7. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.
Burns ER; Zucker-Franklin D
Blood; 1982 Oct; 60(4):1030-7. PubMed ID: 7052160
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.
Valant PA; Jy W; Horstman LL; Mao WW; Ahn YS
Br J Haematol; 1998 Jan; 100(1):24-32. PubMed ID: 9450786
[TBL] [Abstract][Full Text] [Related]
9. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Prog Clin Biol Res; 1990; 337():141-9. PubMed ID: 2191308
[TBL] [Abstract][Full Text] [Related]
10. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
Siddiqui FA; Lian EC
J Clin Invest; 1985 Oct; 76(4):1330-7. PubMed ID: 3932464
[TBL] [Abstract][Full Text] [Related]
11. A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura.
Falanga A; Consonni R; Ruggenenti P; Barbui T
Br J Haematol; 1991 Nov; 79(3):474-80. PubMed ID: 1751375
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
Lian EC
Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregating activity of plasma in patients with thrombotic thrombocytopenic purpura evaluated by a particle counting method using light scattering.
Suehiro A; Yoshimoto H; Higasa S; Kakishita E
Int J Hematol; 1999 Jul; 70(1):40-6. PubMed ID: 10446494
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura: successful treatment unlocks etiologic secrets.
Schmidt JL
Mayo Clin Proc; 1989 Aug; 64(8):956-61. PubMed ID: 2796406
[TBL] [Abstract][Full Text] [Related]
15. Activated platelet aggregates in thrombotic thromboctyopenic purpura: decrease with plasma infusions and normalization in remission.
Ahn YS; Jy W; Kolodny L; Horstman LL; Mao WW; Valant PA; Duncan RC
Br J Haematol; 1996 Nov; 95(2):408-15. PubMed ID: 8904901
[TBL] [Abstract][Full Text] [Related]
16. Electron microscopic study of platelet agglutination induced by thrombotic thrombocytopenic purpura plasma containing 37-KDa platelet agglutinating protein.
Li JZ; Liu JW; Benito G; Siddiqui FA; Lian EC
Thromb Res; 1989 Sep; 55(6):757-66. PubMed ID: 2781535
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Kelton JG
Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
[TBL] [Abstract][Full Text] [Related]
18. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
19. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the role of von Willebrand factor in thrombotic thrombocytopenic purpura.
Lian EC; Siddiqui FA
Blood; 1985 Nov; 66(5):1219-21. PubMed ID: 3876857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
